Orchid Pharma faces liquidation as lenders reject resolution plan

MUMBAI: The lenders to Orchid Pharma have rejected the resolution plan of the bankrupt company, a decision that could push the troubled drug-maker toward liquidation. “The resolution professional has conducted…

USFDA completes inspection of Lupin’s Nagpur plant

New Delhi: Pharma major Lupin today said the US health regulator has completed inspection of its Nagpur facility without making any observations. In a BSE filing, Lupin “announced successful completion…

ASSOCHAM urges greater utilisation of technology in pharmaceuticals

New Delhi: Advanced, affordable and accessible solutions are the only way forward towards intensifying the innovations in the Indian pharmaceutical sector, a top Union Health Ministry official said at an…

Sanofi India net moves up by 37.5% in Q1, Charles Billard will be new CFO

New Delhi: Drug firm Sanofi India on Tuesday reported 37.27 per cent rise in net profit to Rs 82.5 crore for the quarter ended March 31, 2018. The company had…

CDSCO issues show cause notice to Glenmark over clinical trial in Jaipur

The clinical trial of Glenmark Pharma’s osteoarthritis pain medication at a hospital in Jaipur has been flagged by the Central Drugs Standard Control Organisation (CDSCO) over violations like falsification of…

Ajanta Pharma Q4 PAT down 17% at Rs 94 cr

New Delhi: Ajanta Pharma on Wednesday reported 17.13 per cent decline in profit after tax (PAT)at Rs 94.49 crore for the quarter ended March 31, 2018 impacted by decline in…

Abbott discontinues selling Xience Alpine stents in India

New Delhi, Apr 26 : Healthcare firm Abbott today said it has fulfilled all the requirements to discontinue its Xience Alpine drug-eluting stent in India and will not be selling…

Novartis appoints John Tsai as Head of Global Drug Development and CMO

Basel, April 19, 2018 – Novartis announced today the appointment of John Tsai, M.D. as Head of Global Drug Development (GDD) and Chief Medical Officer. Dr. Tsai will join Novartis…

P&G to acquire 52% in Merck India for Rs 1,300cr

MUMBAI: Global consumer products major, The Procter & Gamble Company (P&G), will acquire a nearly 52% stake in drug firm Merck India for Rs 1,300 crore as part of a…

NITI Aayog backs cap on pharma trade margins

New Delhi: Trade margins charged by drug stockists and chemists must be capped, government think tank NITI Aayog recommended, a move that promises to bring down drug prices while trimming…